Description Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading
etiology for chronic liver disease, affecting> 25% of the US and global populations. Up to 1 …

Materials and Methods: PubMed, Embase, and the Cochrane Library databases were
systematically searched to identify studies reporting NAFLD prevalence in the …

Nonalcoholic fatty liver disease (NAFLD) accounts for most cases of chronic liver disease
worldwide, with an estimated global prevalence of approximately 25% and ranges from …

The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased rapidly and is
associated with obesity in epidemiology and pathogenesis. A new study reports that hepatic …

Non-alcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese subjects;
however, it is not rare among lean individuals. Given the absence of traditional risk factors, it …

Nonalcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese or overweight
individuals. However, lean individuals with NAFLD are not rare but represent one significant …

Non-alcoholic fatty liver disease (NAFLD), which approximately affects a quarter of the
world's population, has become a major public health concern. Although usually associated …

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic
dysfunction encountered in general practice. A large proportion of individuals with type 2 …

Abstract Background and Aim Lean non‐alcoholic fatty liver disease (NAFLD) is a potentially
metabolically unhealthy state that refers to NAFLD occurring in non‐overweight/nonobese …

IN BRIEF Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized and
common cause of chronic liver disease worldwide. Although most patients with NAFLD are …